Identification of Marker Genes Including RUNX3 (AML2) That Discriminate Between Different Myeloproliferative Neoplasms and Normal Individuals

Leukemia - United Kingdom
doi 10.1038/leu.2008.41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Myeloproliferative Neoplasms: Morphology and Clinical Practice

American Journal of Hematology
Hematology
2016English

Genetic Complexity of Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

New Classification for Myeloproliferative Neoplasms

Cancer Discovery
Oncology
2018English

Ants Discriminate Between Different Hydrocarbon Concentrations

Frontiers in Ecology and Evolution
EvolutionEcologySystematicsBehavior
2015English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Advances in Understanding and Management of Myeloproliferative Neoplasms

CA - A Cancer Journal for Clinicians
OncologyHematology
2009English

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy